NCT05004064
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05004064
Title Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma (CARAMEL)
Acronym CARAMEL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
The Royal Bournemouth Hospital RECRUITING Bournemouth United Kingdom Details
University Hospital of Wales RECRUITING Cardiff United Kingdom Details
Royal Cornwall Hospital RECRUITING Cornwall United Kingdom Details
Beatson West of Scotland Cancer Centre RECRUITING Glasgow United Kingdom Details
St. Bartholomew's Hospital RECRUITING London United Kingdom Details
University College London Hospital RECRUITING London United Kingdom Details
The Christie Hospital RECRUITING Manchester United Kingdom Details
Clatterbridge Cancer Centre RECRUITING Metropolitan Borough of Wirral United Kingdom Details
Norfolk and Norwich University Hospital RECRUITING Norwich United Kingdom Details
Cancer and Haematology Centre, Churchill Hospital RECRUITING Oxford United Kingdom Details
Derriford Hospital RECRUITING Plymouth United Kingdom Details
Royal Stoke Hospital RECRUITING Stoke-on-Trent United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field